These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 9370119)

  • 21. Effects of passive immunization against parathyroid hormone-related protein: PTHrP is the responsible factor in mediating hypercalcemia in the Walker carcinosarcoma 256 rat model.
    Schilling T; Blind E; Baier R; Sinn HP; Moallem E; Silver J; Ziegler R; Raue F
    J Bone Miner Res; 1995 Jan; 10(1):7-16. PubMed ID: 7747633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serum 1,25-dihydroxyvitamin D may be related inversely to disease activity in breast cancer patients with bone metastases.
    Mawer EB; Walls J; Howell A; Davies M; Ratcliffe WA; Bundred NJ
    J Clin Endocrinol Metab; 1997 Jan; 82(1):118-22. PubMed ID: 8989244
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary excretion of parathyroid hormone-related protein as a predictor of hypercalcemia in patients with adult T-cell leukemia.
    Imamura H; Koreeda Y; Okadome T; Tara M; Niina K; Shizume K; Ohsumi K; Sato K
    Jpn J Clin Oncol; 1992 Oct; 22(5):325-30. PubMed ID: 1469794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercalcemia may indicate Richter's syndrome: report of four cases and review.
    Beaudreuil J; Lortholary O; Martin A; Feuillard J; Guillevin L; Lortholary P; Raphael M; Casassus P
    Cancer; 1997 Mar; 79(6):1211-5. PubMed ID: 9070500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma levels of parathyroid hormone-related peptide are elevated in hyperprolactinemia and correlated to bone density status.
    Stiegler C; Leb G; Kleinert R; Warnkross H; Ramschak-Schwarzer S; Lipp R; Clarici G; Krejs GJ; Dobnig H
    J Bone Miner Res; 1995 May; 10(5):751-9. PubMed ID: 7639111
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
    J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Passive immunization with anti-parathyroid hormone-related protein monoclonal antibody markedly prolongs survival time of hypercalcemic nude mice bearing transplanted human PTHrP-producing tumors.
    Sato K; Yamakawa Y; Shizume K; Satoh T; Nohtomi K; Demura H; Akatsu T; Nagata N; Kasahara T; Ohkawa H
    J Bone Miner Res; 1993 Jul; 8(7):849-60. PubMed ID: 8352067
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [PTH-related protein (PTHrP) in serum of patients with tumor hypercalcemia].
    Scharla SH; Pecherstorfer M; Lempert UG; Minne HW; Sarrach M; Baumgartner G; Ziegler R
    Med Klin (Munich); 1991 Apr; 86(4):186-9. PubMed ID: 2056982
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-alpha and interferon-gamma in serum of multiple myeloma patients.
    Pisa P; Stenke L; Bernell P; Hansson M; Hast R
    Anticancer Res; 1990; 10(3):817-20. PubMed ID: 2114819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parathyroid hormone (PTH)-related protein, PTH, and 1,25-dihydroxyvitamin D in dogs with cancer-associated hypercalcemia.
    Rosol TJ; Nagode LA; Couto CG; Hammer AS; Chew DJ; Peterson JL; Ayl RD; Steinmeyer CL; Capen CC
    Endocrinology; 1992 Sep; 131(3):1157-64. PubMed ID: 1505457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of parathyroid hormone-related protein as a factor stimulating bone resorption and causing hypercalcemia in myeloma.
    Tsujimura H; Nagamura F; Iseki T; Kanazawa S; Saisho H
    Am J Hematol; 1998 Oct; 59(2):168-70. PubMed ID: 9766803
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women.
    Packer E; Holloway L; Newhall K; Kanwar G; Butterfield G; Marcus R
    J Bone Miner Res; 1990 Aug; 5(8):877-84. PubMed ID: 2173358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypercalcemia induced with the plasma levels of parathyroid hormone-related peptide in multiple myeloma.
    Shionoiri A; Horiuchi T; Onouchi T; Tsutsumi H; Ohta M; Hosoi T; Ito H; Orimo H
    Intern Med; 2000 Oct; 39(10):810-3. PubMed ID: 11030205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parathyroid hormone-related protein, parathyroid hormone, and vitamin D in hypercalcemia of malignancy.
    Motellón JL; Javort Jiménez F; de Miguel F; Jaras MJ; Díaz A; Hurtado J; Esbrit P
    Clin Chim Acta; 2000 Jan; 290(2):189-97. PubMed ID: 10660809
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of parathyroid hormone-related protein in cats with humoral hypercalcemia of malignancy.
    Bolliger AP; Graham PA; Richard V; Rosol TJ; Nachreiner RF; Refsal KR
    Vet Clin Pathol; 2002; 31(1):3-8. PubMed ID: 12019470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
    Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions.
    Kao PC; Klee GG; Taylor RL; Heath H
    Mayo Clin Proc; 1990 Nov; 65(11):1399-407. PubMed ID: 1700240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parathyroid hormone-related protein: elevated levels in both humoral hypercalcemia of malignancy and hypercalcemia complicating metastatic breast cancer.
    Grill V; Ho P; Body JJ; Johanson N; Lee SC; Kukreja SC; Moseley JM; Martin TJ
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1309-15. PubMed ID: 1955513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypercalcemia in a patient with B-cell acute lymphoblastic leukemia: a role of proinflammatory cytokine.
    Fukasawa H; Kato A; Fujigaki Y; Yonemura K; Furuya R; Hishida A
    Am J Med Sci; 2001 Aug; 322(2):109-12. PubMed ID: 11523624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.